Items where authors include "Kennedy, J."

Article

Field, J. orcid.org/0000-0002-5462-4156, Sabev, B. orcid.org/0009-0004-7097-8079, Davies, J. orcid.org/0000-0001-5888-664X et al. (4 more authors) (2025) Recommendations for enhancing oral health professional education through the student voice: the ADEE‐EDSA partnership in action. European Journal of Dental Education, 29 (4). pp. 664-670. ISSN 1396-5883

Costello, R.E. orcid.org/0000-0003-2709-6666, Parker, M., Kennedy, J. et al. (274 more authors) (2025) Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK. Rheumatology. keaf559. ISSN 1462-0324

Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2025) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Pagnamenta, A.T. orcid.org/0000-0001-7334-0602, Hashim, M. orcid.org/0000-0003-3395-8453, Kennedy, J. et al. (4 more authors) (2025) A cryptic CBFB deletion–inversion expands the mutational spectrum of variants associated with cleidocranial dysplasia. Clinical Genetics, 108 (1). pp. 86-91. ISSN 0009-9163

Forster, P.M. orcid.org/0000-0002-6078-0171, Smith, C., Walsh, T. et al. (58 more authors) (2025) Indicators of Global Climate Change 2024: annual update of key indicators of the state of the climate system and human influence. Earth System Science Data, 17 (6). pp. 2641-2680. ISSN 1866-3508

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Keating, C., Yonker, L.M., Vermeulen, F. et al. (320 more authors) (2025) Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. The Lancet Respiratory Medicine, 13 (3). pp. 256-271. ISSN 2213-2600

Forster, P.M. orcid.org/0000-0002-6078-0171, Smith, C. orcid.org/0000-0003-0599-4633, Walsh, T. et al. (56 more authors) (2024) Indicators of Global Climate Change 2023: annual update of key indicators of the state of the climate system and human influence. Earth System Science Data, 16 (6). pp. 2625-2658. ISSN 1866-3508

Borrego-Yaniz, G., Ortiz-Fernández, L., Madrid-Paredes, A. et al. (291 more authors) (2024) Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology, 6 (6). e374-e383. ISSN 2665-9913

Huang, L., Bon, H., Maamra, M. et al. (11 more authors) (2024) The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease. PLOS ONE, 19 (5). e0298864. ISSN 1932-6203

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Oates, S., Absoud, M., Goyal, S. et al. (32 more authors) (2021) ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder. Clinical Genetics, 100 (4). pp. 412-429. ISSN 0009-9163

Kennedy, J., Hembry, P., Green, D. et al. (2 more authors) (2020) Predictors of change in global psychiatric functioning at an inpatient adolescent psychiatric unit: A decade of experience. Clinical Child Psychology and Psychiatry, 25 (2). pp. 471-482. ISSN 1359-1045

Kennedy, J. and Smith, A.S.J. (2004) Assessing the efficient cost of sustaining Britain’s rail network perspectives based on zonal comparisons. Journal of Transport Economics and Policy, 38 (2). pp. 157-190. ISSN 0022-5258